Advertisement


Charles F. von Gunten, MD, PhD, on Referrals for Hospice Care: A Quality Improvement Approach

2016 Palliative Care in Oncology Symposium

Advertisement

Charles F. von Gunten, MD, PhD, of OhioHealth, discusses hospice care as a measure of quality, and findings that show medical oncologists doubled the median length of hospice service from 20 days to 40 days (Abstract 45).



Related Videos

Palliative Care
Issues in Oncology

Sriram Yennu, MD, on Patient Perception of Curability

Sriram Yennu, MD, of The University of Texas MD Anderson Cancer Center, discusses findings from a study of an international cohort of patients with advanced cancer who received palliative care. Nearly half the patients incorrectly believed their cancer was curable (Abstract 5).

Hematologic Malignancies
Supportive Care
Palliative Care

Eileen Danaher Hacker, PhD, APN, AOCN: After Stem Cell Transplant: Enhancing Recovery With Strength Training

Eileen Danaher Hacker, PhD, APN, AOCN, of the University of Illinois at Chicago, discusses study findings that show improvement in physical activity, fatigue, muscle strength, and functional ability (Abstract 190).

Palliative Care
Issues in Oncology

J. Nicholas Dionne-Odom, PhD, on Supporting Family Caregivers: The ENABLE Model

J. Nicholas Dionne-Odom, PhD, of the University of Alabama at Birmingham, discusses the “hidden” health-care workforce of family caregivers and what clinicians can do to help ease the burden on families.

Palliative Care
Issues in Oncology

Charles D. Blanke, MD, on Oregon’s Death With Dignity Act

Charles D. Blanke, MD, of the Oregon Health & Science University and Southwest Oncology Group, discusses the nearly 20 years’ experience with Oregon’s Death With Dignity (DWD) Act, a voter initiative that led to the first such law enacted in the United States (Abstract 44).

Pain Management
Global Cancer Care
Palliative Care

James F. Cleary, MD, on Global Access to Opioids

James F. Cleary, MD, of the University of Wisconsin Carbone Cancer Center, talks about the many reasons that 80% of the world’s population lacks access to opioids, the mainstay of cancer pain management.

Advertisement

Advertisement



Advertisement